CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $48 From $52, Maintains Outperform Rating

Neutral
AI Analysis

Summary

Oppenheimer adjusted its price target on Corbus Pharmaceuticals from $52 to $48 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
0.00
price_targetanalyst_rating
Related Companies

Read the original article

Published by yahoo_finance on August 7, 2026 1:18 PM

Read Original